NCT06348134
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06348134
Title Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Chicago Illinois 60615 United States Details
Lagos State University Teaching Hospital Ikeja Lagos 100271 Nigeria Details
Lagos University Teaching Hospital Yaba Lagos 100254 Nigeria Details
Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC) Ile-Ife Osun State 220005 Nigeria Details
University of Ibadan Hospital Ibadan Oyo State 200285 Nigeria Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field